Menora Mivtachim Holdings Ltd 13D and 13G filings for UroGen Pharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 1:23 pm Unchanged |
2025-03-11 | 13G | UroGen Pharma Ltd. URGN |
Menora Mivtachim Holdings Ltd | 2,303,031 4.990% |
0 (Unchanged) |
Filing |
| 2024-11-14 12:04 pm Unchanged |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
Menora Mivtachim Holdings Ltd | 2,303,031 5.470% |
0 (Unchanged) |
Filing |
| 2024-02-14 10:02 am Sale |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
Menora Mivtachim Holdings Ltd | 2,303,031 7.460% |
-615,971 (-21.10%) |
Filing |
| 2023-06-12 08:47 am Sale |
2023-06-12 | 13G | UroGen Pharma Ltd. URGN |
Menora Mivtachim Holdings Ltd | 2,919,002 12.450% |
-35,697 (-1.21%) |
Filing |
| 2021-02-11 07:28 am Unchanged |
2020-12-31 | 13G | UroGen Pharma Ltd. URGN |
Menora Mivtachim Holdings Ltd | 2,954,699 13.370% |
0 (Unchanged) |
Filing |